$1.66
-0.10-5.68%
Last update: Oct 30, 5:27 PM
Acrivon Therapeutics Inc (ACRV) Stock Price, Quote, News & History
ACRVNASDAQ
Acrivon Therapeutics shares new trial data showing strong cancer responses, early tumor shrinkage, and pipeline progress, while confirming cash runway into...
You can purchase shares of Acrivon Therapeutics (NASDAQ:ACRV) through any online brokerage.
Other companies in Acrivon Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Acrivon Therapeutics has a consensus price target of $17.75.
The stock price for Acrivon Therapeutics (NASDAQ: ACRV) is $1.7 last updated October 30, 2026 at 5:27 PM EDT.
There are no upcoming dividends for Acrivon Therapeutics.
Acrivon Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Acrivon Therapeutics.
Acrivon Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient...
